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The COMT Val108/158Met polymorphism has been extensively studied in relation to individual differences in
working memory (WM) performance. The present study tested the association of the COMT Val108/158Met
polymorphism with WM performance in two independent family-based Dutch samples: 371 children
(mean age 12.4 years) and 391 adults (mean age 36.2 years). A significant association was found between
the COMT polymorphism and WM scores in the combined adult and young cohorts. The association
reflected positive heterosis such that the Met/Met and Val/Val homozygotes did not perform as well as the
Met/Val heterozygotes on the WM tasks. A secondary analysis was conducted in which a DRD2-tagging
SNP (rs2075654) was tested for an interactive effect with the COMT polymorphism on WM performance. A
significant interactive effect of the DRD2 and COMT genes was found such that heterosis was present only
in the DRD2 genotype that has been linked to lower receptor density. Our results support previous findings
that WM performance needs an optimal level of dopamine signaling within the PFC. This optimum level
depends on enzymatic activity controlling dopamine level as well as dopamine receptor sensitivity, both of
which may differ as a function of age and genotype. We conclude that the effects of a single polymorphism
in a dopaminergic gene on a well-defined cognitive trait may easily remain hidden if the interaction with
age and other genes in the pathway are not taken into account.
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Introduction
Working memory (WM) is a fundamental component of
human intelligence.1,2 It refers to the processes that
support the short-term maintenance or manipulation of
relevant information in the presence of distracting irrele-
vant information. Nonhuman primates physiology and
human functional imaging studies support a critical
involvement of the prefrontal cortex (PFC) in WM.3,4 The
PFC is the primary target of extensive dopamine (DA)
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projections from the midbrain, and several lines of
evidence suggest that the frontal DA level is a critical
modulator of WM performance.1,5 Hence, genes involved
in dopaminergic pathway metabolism have been of
particular interest to explain individual differences in
WM performance.6 – 11 Amongst these, the catechol-O-
methyltransferase (COMT) gene has been studied the most
extensively. The COMT gene is located on chromosome
22q11, and contains six exons.12 It is involved in
enzymatic activity that degrades DA, norepinephrine, and
epinephrine.13 Two promoters encoding different isoforms,
a membrane-bound COMT (MB-COMT) and a soluble
COMT (S-COMT), are known. Both transcripts start at exon
3.14 Differential expression and activity profiles have been
well characterized, MB-COMT is predominantly expressed
in brain neurons,15 whereas S-COMT is predominantly
expressed in other tissues, such as liver, blood, and
kidney.14 The human MB-COMT plays a crucial role in
regulation of DA signaling at the PFC level. It contains a
common functional single-nucleotide polymorphism
(SNP) (rs4680) that substitutes a Val for a Met residue at
codon 158 (see Figure 1).
The Met allele encodes an enzyme with relatively lower
activity,16 and is thought to be specific to humans; as no
equivalent polymorphism has been found in any other
species.17 Decrease in enzyme activity present in Met/Met
individuals, compared to individuals homozygous for the
Val allele, leads to a relatively higher DA availability,
whereas Met/Val heterozygous display an intermediate
enzyme activity.18 Because frontal DA level is a critical
modulator of WM processes, the decreased COMT activity
of Met carriers might be beneficial to their cognitive
performance. In line with this, Savitz et al10 found that
20 of the 26 studies on the association between the COMT
Val108/158Met polymorphism and cognitive function re-
ported a significant association. All but two of these studies
suggested that the low-activity Met allele yields better
performance on cognitive tasks that have a WM compo-
nent. However, these studies were often based on small
and/or clinical samples (ADHD in children; schizophrenia
in adults) and no significant association to WM was found
in a much larger sample of healthy adult males.19 In
addition, Mattay et al20 have shown that the role of the
COMT Val108/158Met polymorphism in PFC function,
particularly in WM performance, is not straightforward.
Although homozygous individuals for the Met allele
perform significantly better than individuals homozygous
for the Val allele, when the Met homozygotes are given DA
agonists their response actually deteriorates. In contrast,
the response of the ‘dopamine-poor’ Val homozygotes
improves with DA agonists. This suggests that the relation
between DA availability at the PFC level as indexed by
COMT activity and WM performance is not linear, but
instead follows an inverted-U shape.
DA signaling, furthermore, is not only dependent on the
availability of DA, but also on the efficiency of the DA
receptor and its downstream signaling cascade. Because of
their importance in reward processing, dopaminergic
receptors, in particular the DA D2 receptor gene (DRD2),
have been studied extensively in addiction research.21 The
DRD2 gene is located on chromosome 11 at q22-q23 (see
Figure 2). A DRD2 Taq IA variant, a restriction fragment
length polymorphism (RFLP), located on the 30 untrans-
lated region (30UTR) of the DRD2 gene, is associated with
altered receptor density.22 Individuals with the A1 allele
show a 30–40% reduction in D2 DA receptor density
compared with those homozygous for the A2 allele.22,23
Recently, Reuter et al24 conducted an association analysis
using an adult cohort enriched for COMT and DRD2
homozygotes. They found a significant interaction bet-
ween DRD2 Taq IA and COMT Val108/158Met polymorph-
isms, and performance on response interference on the
Stroop color–word conflict task. Met homozygotes per-
formed better than Val allele carriers, but only if they had
the DRD2 genotype associated with low receptor density.
In fact, Met homozygotes also bearing two DRD2 A2 alleles
showed a significantly worse performance compared to all
other genotypes. Although response interference and WM
are not unitary constructs, we showed a significant
correlation (r¼0.26, Po0.05) between these two mea-
sures of PFC function.25 Hence, we hypothesize that a
COMT by DRD2 interaction may also be found for WM
performance.
Figure 1 COMT gene and functional single-nucleotide polymorph-
ism (SNP) rs4680 on 22q11.21.
Figure 2 DRD2 gene and tagging SNP rs2075654 near the
restriction site Taq A1 on 11q23. * indicates splicing site at exon 6.
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In the present study, which included 762 genotyped
subjects, from two independent family-based Dutch sam-
ples of 371 (mean age 12.4 years) and 391 (mean age 36.2
years) subjects, respectively, our principal goal was to test
for association of the COMT Val108/158Met polymorphism
with WM performance. The use of a family-based sample
made it possible to test for association in a combined
within- and between-family design to estimate genetic
effects, which are free from spurious effects of population
stratification.26 As a secondary analysis, we tested for an
interactive effect of the COMT Val108/158Met polymorph-
ism and genetic variation in the DRD2 gene on WM
performance comparable to the effect reported by Reuter
et al24 for Stroop interference. Because DA receptor
sensitivity has been shown to decline with aging in both
animal27 and human studies,28 our analyses will allow this
interaction to be different in children and adults.
Materials and methods
Subjects
All twins and their siblings were part of two larger cognitive
studies and were recruited from the Netherlands Twin
Registry.29 Informed consent was obtained from the
participants (adult cohort) or from their parents if they
were under 18 years of age (young cohort). The current
study was approved by the institutional review board of the
VU University Medical Center. None of the individuals
tested suffered from severe physical or mental handicaps,
as assessed through standard questionnaire.
Young cohort
The young cohort consisted of 177 twin pairs born between
1990 and 1992, and 55 siblings,30,31 of which 371 were
available for genotyping. The genotyped twins were 12.4
(SD¼0.9) years of age and the siblings were between 8 and
15 years of age at the time of testing. There were 35
monozygotic male twin pairs (MZM), 28 dizygotic male
twin pairs (DZM), 48 monozygotic female twin pairs (MZF),
23 dizygotic female twin pairs (DZF), 26 dizygotic opposite-
sex twin pairs (DOS), 24 male siblings and 24 female
siblings, and 3 subjects form incomplete twin pairs (1 male,
2 females). Participation in this study included a voluntary
agreement to provide buccal swabs for DNA extraction.
Adult cohort
A total of 793 family members from 317 extended twin
families participated in the adult cognition study.32
Participation in this study did not automatically include
DNA collection, however, part of the sample, 276 subjects
returned to the lab to provide blood samples, 115 provided
buccal swabs through the biobanking project33 for DNA
extraction. Mean age of the genotyped sample was 36.2
years (SD¼12.6). There were 25 monozygotic male twin
pairs (MZM), 15 dizygotic male twin pairs (DZM), 1 DZM
triplet, 20 monozygotic female twin pairs (MZF), 28
dizygotic female twin pairs (DZF), 23 dizygotic opposite-
sex twin pairs (DOS), 29 female siblings, 28 male siblings,
and 109 subjects from incomplete twin pairs (41 males, 68
females).
Cognitive testing
WM tasks were assessed in the young cohort, using the
Dutch adaptation of the Wechsler Intelligence Scale for
Children-Revised (WISC-R)34 consisting of two subtests:
arithmetic and digit span. WM performance was indexed as
the sum score of the two subtests and corrected for age and
sex. The Dutch adaptation of the Wechsler Adult Intelli-
gence Scale III-Revised (WAIS-IIIR)35 was used to assess WM
performance in the adult cohort and consisted of two
subtests taxing WM (arithmetic and letter–number se-
quencing). WM was indexed as the sum score of arithmetic
and letter-number sequencing and corrected for age and
sex.
DNA collection and genotyping
DNA isolation from buccal swabs was performed using a
chloroform/isopropanol extraction36 DNA was extracted
from blood samples using the salting out protocol.37
Zygosity was assessed using 11 polymorphic microsatellite
markers (Het40.80). Genotyping was performed blind to
familial status and phenotypic data. Both MZ twins of a
pair were included, serving as additional quality control on
genotyping. COMT genotyping was performed using
fluorogenic probes in the high-throughput 50-nuclease
assay and following manufacturer’s recommendations
(TaqMan, PE Applied Biosystems, Foster city, CA, USA).
For DRD2, instead of the A1 allele of the Taq IA
polymorphism, a tag-SNP (rs2075654) lying 18 kb down-
stream of the Taq IA variant was genotyped. LD between
rs2075654 and Taq IA was calculated using the CEPH
population, which is presumably of similar genetic ances-
try to the Dutch population. LD between these two
polymorphisms was high (r2¼0.65, LOD score 14.14). In
view of the LD between the tag-SNP and Taq IA, we will
refer to the T allele as ‘A1’. DRD2-SNP genotyping was
performed as part of a SNPlex assay, which included
multiple other genes, following a tagging approach.38
The SNPlex assay was conducted following the manufac-
turer’s recommendations (Applied Biosystems). Here we
focus on the DRD2 gene only. Results on cognitive effects
of two other genes are described elsewhere.39,40
Statistical analyses
Allele frequencies of the COMT Val108/158Met and DRD2
A1/A2 polymorphisms were estimated in both cohorts
using Haploview (http://www.broad. mit.edu/mpg/haplo-
view), in which a Hardy–Weinberg test is implemented,
based on an exact calculation of the probability of
observing a certain number of heterozygotes conditional
DA system and PFC functioning
MF Gosso et al
1077
European Journal of Human Genetics
on the number of copies of the minor SNP allele. Family-
based genetic association tests were conducted using the
program QTDT (http://www.sph.umich.edu/csg/abecasis/
QTDT/), which implements the orthogonal association
model proposed by Abecasis et al41 (see also Fulker et al42
extended by Posthuma et al43) This model allows one the
decomposition of the genotypic association effect into
orthogonal between- (bb) and within- (bw) family compo-
nents and can incorporate fixed effects of covariates and
can also model the residual sib-correlation as a function of
polygenic or environmental factors. MZ twins can be
included and are modeled as such, by adding zygosity
status to the data file. They are not informative to the
within-family association component (unless they are
paired with non-twin siblings) but are informative for the
between family component. The between-family associa-
tion component is sensitive to population admixture,
whereas the within-family component is significant only
in the presence of true association. Testing for the equality
of the bb and bw effects serves as a test of population
stratification. If population stratification acts to create a
false association, the test for association using the within-
family component (bb) is still valid and provides a
conservative test of association. If this test is not signifi-
cant, the between- and within-family effects are equal and
the more powerful association test that uses the whole
population at once can be applied. The residual sib
correlation was modeled as a function of residual genetic
variance and non-shared environmental variance. The
DRD2 genotype was recoded into carriers (A1þ ) versus
non-carriers (A1). We used one-sided hypothesis testing
for the interaction effects as our hypotheses specify the
direction of genetic effects.
Results
In total, 762 subjects were available for SNP genotyping.
Based on blind controls and intrapair MZ comparisons, a
low genotyping error rate was found (0.015%). For the total
sample, the success rate was 98.5 and 93.4% for the COMT
Val108/158Met polymorphism in the young and adult
cohort, respectively. For DRD2 rs2075654, success rates
were 97 and 100%, 365 adults and 360 children had
genotype data for both COMT and DRD2. The distribution
of genotype and allele frequencies of the COMT and DRD2
polymorphisms as well as means, standard deviations, and
standard errors for WM performance are provided in
Table 1. Phenotypic means are provided for the complete
phenotypic sample as well as for the genotyped
subsamples.
Stratification
Tests for the presence of population stratification were
not significant at the 0.05 level (COMT: w2(1360)¼ 0.937,
P¼0.33; w2(1360)¼0.23, P¼0.64; w2(1724)¼1.516, P¼0.22; for
children, adults and the combined sample, respectively)
(DRD2: w2(1355)¼0.220, P¼0.64; w2(1388)¼0.00, P¼0.9976;
w2(1748)¼0.084, P¼0.77; for children, adults and the
combined sample, respectively), indicating that genotypic
effects within families were not significantly different from
those observed between families, suggesting that the more
powerful population-based association test can be meaning-
fully interpreted for both COMT and DRD2.
COMT polymorphism
WM performance was compared across the three possible
genotype groups (Met/Met, Met/Val, and Val/Val) suggesting
Table 1 Means and standard deviations WM scores for COMT and DRD2 genotypes
Cohort Genotype N Frequency WM mean Standard deviation Standard error of mean
Young
Total phenotypic sample 407 22.88 4.85 0.24
Genotyped sample 371 22.90 4.89 0.25
COMT Met/Met 117 0.32 22.51 4.96 0.46
N¼365 Met/Val 175 0.48 23.49 5.06 0.38
Val/Val 73 0.20 22.27 4.33 0.51
DRD2 A1A1 9 0.03 23.98 2.08 0.69
N¼360 A1A2 94 0.26 23.12 5.10 0.53
A2A2 257 0.71 22.78 4.88 0.30
Adult
Total phenotypic sample 793 109.91 15.89 0.56
Genotyped sample 391 109.92 15.80 0.80
COMT Met/Met 112 0.31 108.48 15.73 1.49
N¼365 Met/Val 168 0.46 111.51 14.89 1.16
Val/Val 85 0.23 107.77 17.02 1.84
DRD2 A1A1 16 0.04 104.96 14.66 3.67
N¼391 A1A2 109 0.27 110.76 14.25 1.36
A2A2 266 0.69 110.36 16.32 1.00
Note: The WM scores of children and adults are based on different subtests. Although these index the same theoretical construct, the WM scores
cannot be compared directly across age cohorts.
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a positive heterosis pattern in both the young and the adult
cohorts (see Table 1). Heterosis refers to a situation in
which a given trait is significantly greater (or lesser) in
individuals heterozygous at a specific gene marker than
those homozygous for either allele. We tested for heterosis
by adding a non-additive (dominance) genetic component
to the population-based analysis in QTDT and testing
whether the heterozygous genotypes were associated with
better WM performance. A significant heterosis effect was
found for the association between COMT Val108/158Met
polymorphism and WM in the adult cohort (w2(1360)¼4.80,
P¼0.014) even after correction for multiple testing. In the
young cohort, the association did not reach significance
(w2(1360)¼1.54, P¼0.107), although the effects were in the
same direction as in the adult cohort. The strongest effect
was found in the combined sample (w2(1724)¼5.70,
P¼0.008).
DRD2 polymorphism
No significant main effect was found on the DRD2
rs2075654 tag-SNP and WM performance (w2(1,356)¼0.42
P¼0.52; w2(1,391)¼ 0.04 P¼0.84; and w2(1749)¼0.10 P¼0.75,
for children, adults, and the combined sample, respectively).
COMT and DRD2 interaction
Figure 3 plots WM performance against six possible com-
bined genotype groups (Met/Met,A; Val/Met,A; Val/
Val,A; Met/Met;Aþ ; Val/Met,Aþ and Val/Val,Aþ ). The
figure suggests that the heterosis found for the COMT gene is
entirely limited to subjects with the DRD2 Aþ genotype, the
genotype previously linked to the reduced receptor density.
In support of this, a significant interaction effect was detected
between the DRD2 and COMT polymorphisms in the
combined sample (w2(1699)¼2.72, one-sided P¼0.050), which
seemed confined to the adult cohort (see Table 2).
Figure 3 Working memory (WM) means plotted for the six combined genotype groups of the COMT and DRD2 genes for young (left panel) and
adult (right panel) cohort. Bars denote standard error. Note: Aþ denotes carriers of the A1 allele, whereas A- denotes non-carriers.
Table 2 Results of population-based gene–gene interaction analysis – for COMT Val108/158Met, and DRD2 rs2075654
(tagging the TaqA1 polymorphism) for the young, adult, and combined cohorts
Cohort Model 2 lnlk df vs w2 P-valuea
Young 1. Full model including main effects COMT and DRD2+additive and
heterosis interaction effects
952.64 350
2. Test for significance of heterosis interaction COMTDRD2 953.70 351 1 1.06 0.152
3. Test for significance of additive interaction COMTDRD2 954.32 352 2 0.62 0.216
Adult 1. Full model including main effects COMT and DRD2+additive and
heterosis interaction effects
926.38 340
2. Test for significance of heterosis interaction COMTDRD2 927.62 341 1 1.24 0.133
3. Test for significance of additive interaction COMTDRD2 929.16 342 2 1.54 0.107
All 1. Full model including main effects COMT and DRD2+additive and
heterosis interaction effects
1881.9 698
2. Test for significance of heterosis interaction COMTDRD2 1884.62 699 1 2.72 0.050
3. Test for significance of additive interaction COMTDRD2 1886.32 700 2 1.7 0.096
aOne-sided P-value.
Note: Model 1¼ full model, includes a grand mean, main additive and heterosis effects of COMT, a main effect of A1 carriers versus non carriers of
DRD2, and additive and heterosis interaction of COMT genotypesDRD2 A1 carriers versus non-carriers. Model 2¼model 1, except the heterosis
interaction. Model 3¼model 2, except the additive interaction.
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Discussion
In the present study, we tested the association of the COMT
Val108/158Met polymorphism with WM performance. A
significant association was found in the combined sample
with stronger contribution from the adult than the young
cohort. The association reflected positive heterosis such
that the Met/Val heterozygotes performed better than both
Met/Met and Val/Val homozygotes on the WM tasks. An
age-dependent positive heterosis pattern has previously
been reported in a longitudinal study by Harriset al.44 The
COMT genotype was not associated with childhood
intelligence measured at the age of 11 years in the Scottish
Mental Survey of 1932. At the age of 79 years, COMT
genotype was significantly related to differences in verbal
declarative memory and to scores on the personality traits
of intellect/imagination. For both traits, the elderly Val/
Met heterozygotes had higher scores than both homo-
zygous groups, which echo the pattern of heterosis on WM
found in adult cohort. Because the COMT polymorphism
has been hypothesized to have a nonlinear effect on DA
availability in the prefrontal cortex,20 the finding of
heterosis is in keeping with the idea that the relationship
between DA signaling and cognitive performance follows
an inverted U-shaped curve, with both suboptimal and
supraoptimal DA activity, impairing prefrontal function.45
Burst firing of VTA neurons causes synaptic DA release in
pyramidal cells in the PFC. Because these cells contain little
DA transporter (DAT), most DA diffuses out of the synaptic
cleft to bind to extrasynpatic D1 receptors, where it is
inactivated by COMT.46 The higher activity Val allele
decreases extrasynaptic DA levels and, therefore, D1
activation, shifting the balance in favor of intrasynaptic
D2 receptor activation.46,47 Cognitive performance may be
critically dependent on the D1/D2 binding ratio, with a
relative lack of D1 signaling causing impulsivity, distracti-
bility, and poor WM performance with schizophrenia at
the extreme end.47 A relative lack of D2 signaling, on the
other hand, may fail to signal the presence of reward
information, a signal that is required to engage the PFC in
updating its WM system.48
The above suggests that the optimum level of DA
signaling depends not simply on frontal DA availability,
but on its combination with D2 receptor sensitivity.
Therefore, individual differences in DA availability as well
as D2 receptor sensitivity may come into play during the
performance of WM tasks. We tested this expectation in a
secondary analysis in which a DRD2 tagging SNP
(rs2075654) was tested for an interactive effect with the
COMT polymorphism. No significant main effect on WM
was found for the rs2075654 tag-SNP in DRD2. However, in
the combined cohort, the DRD2 and COMT polymorph-
isms had a significant interactive effect on WM perfor-
mance. The interaction suggested that the Met/Val
heterozygotes perform better than both Met/Met and Val/
Val homozygotes only when they carry one or two A1
alleles. The A1 alleles have been associated with lower
receptor density, suggesting that the U-curve-shaped effect
of DA availability on WM performance disappears when
receptor density is high. Such a pattern has been previously
reported by Reuter et al,24 who reported a significant
interactive effect between the DRD2 Taq IA and the COMT
polymorphisms on the amount of response interference in
the Stroop color–word conflict task. Inspection of Figure 3
suggests that the interaction is stronger in the adult than in
the young cohort. Although p-values in neither cohort
reach formal significance levels, this age difference may be
real. Evidence for age-related changes regarding DA
metabolism within the PFC has been postulated in both
animal27 and human studies,28 with increased DA meta-
bolism (eg, MAO, COMT) thought to be present at a more
mature age.49 Furthermore, several lines of evidence
showed a decrease of DA receptors with age.50 – 52 When
age-related changes in overall levels of DA availability and
DA receptor sensitivity are superimposed on the influence
of genetic polymorphisms on these levels, a different
change in overall DA signaling may occur with age in the
various COMT–DRD2 haplotypes. When we add to this
that there may be an inverted U-curved relation between
DA signaling and WM performance, interactions between
age, DRD2, and COMT genes should be the rule rather than
the exception.
Clearly, full genetic contribution to dopaminergic varia-
tion in frontal executive function will rely on far more
complex interactions between multiple receptor (eg, DRD1,
DRD2, and DRD4), transporters and enzymatic polymorph-
isms (eg, DAT, COMT, and MAO).9,53,54 Further studies
systematically involving such interactions are needed to
obtain a clearer overview of the dopaminergic pathway. At
the same time, denser SNP coverage of the area under study
is needed in genes like DRD2 to reveal the true functional
variants, which while tagged, are still undiscovered. In
summary, our results are in keeping with previous findings
suggesting that WM performance needs an optimal level of
DA signaling within the PFC. This optimum level depends
on enzymatic activity controlling DA level as well as on DA
receptor sensitivity, both of which may differ as a function
of age and genotype. We conclude that the effects of a
single polymorphism in a dopaminergic gene on a well-
defined cognitive trait may easily remain hidden if the
interaction with age and other genes in the pathway are
not taken into account.
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